Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and production method of combined inactivate vaccine

A dual inactivated vaccine, pleuropneumonia technology, applied in biochemical equipment and methods, vaccines, multivalent vaccines, etc., can solve problems such as abortion of ewes, intradermal immunization, and death of lambs

Inactive Publication Date: 2019-03-12
CHINA INST OF VETERINARY DRUG CONTROL
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, the goat pox live vaccine widely used in my country has been tested by long-term clinical practice and found to have the following three major deficiencies. Larger potential safety hazards; second, it is necessary to use primary sheep testicular cells to prepare vaccines, and the source of sheep testes is difficult in the production process, and there is a biosafety risk of primary cells carrying exogenous viruses; third, intradermal immunization is required, Difficult to handle during clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and production method of combined inactivate vaccine
  • Combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and production method of combined inactivate vaccine
  • Combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and production method of combined inactivate vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] —— Vaccine preparation and testing

[0048] According to the established production process, three batches of inactivated vaccines for sheep pox and goat infectious pleuropneumonia were prepared, and the results are reported as follows.

[0049] 1. Materials

[0050] (1) The cells used for cell production are BHK-21 suspension cells.

[0051] (2) Virus sheep pox virus AV41 strain and AV40 strain.

[0052] (3) Bacterial strains for strain production: goat infectious pleuropneumoniae Mycoplasma C87001 strain, F8 generation, live bacterial titer is 1×10 9.0 CCU / ml; Bacteria used for inspection: goat infectious pleuropneumonia C87002 strain tissue freeze-dried virus, code name 87002, generation: 52 generations, specification: 1.0g / bottle, identified, kept and supplied by the China Veterinary Drug Control Institute.

[0053] (3) Oil adjuvant Montanide ISA 201 adjuvant, produced by SEPPIC, France.

[0054] (4) The 3-month-old and 1-year-old experimental animals were healt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a combined inactivate vaccine for sheep pox and contagious caprine pleuropneumonia (CCPP), and a production method of the combined inactivate vaccine. The method comprises thesteps of inoculating suspension cultured BHK-21 cells and a proper culture medium with a capripox virus AV41 strain and a mycoplasma capricolum pneumonia subspecies C87001 strain respectively for culturing, harvesting the culture, concentrating and purifying; inactivating with BEI and thimerosal respectively, adding a suitable adjuvant according to a certain proportion, mixing and emulsifying. The combined inactivate vaccine is used for preventing the sheep pox and the CCPP. The combined inactivate vaccine, provided by the invention, for the sheep pox and the CCPP is obtained internationallyfor the first time, and can achieve the aim of preventing the two diseases by means of one injection; furthermore, a live vaccine for the sheep pox is produced by means of the suspension cultured BHK-21 cells; compared with the original inactivate vaccine prepared from ovine testicular cells, the combined inactivate vaccine provided by the invention has obvious advantages, and can solve the problems that in the production process of the live vaccine for the sheep pox, the sheet testis is difficult to obtain, lamb death and ewe abortion are easily caused, subcutaneous immunization needs to be performed when the vaccine is used, an operation is difficult during clinical application, and the like.

Description

technical field [0001] The invention relates to a dual inactivated vaccine of sheep pox and goat infectious pleuropneumonia and a production method thereof. It belongs to the field of veterinary biological products. Background technique [0002] The sheep raising industry is closely related to the development of the national economy and the improvement of the living standards of the people of all ethnic groups. Especially after entering the 21st century, the sheep raising industry in my country has developed rapidly with remarkable results, and the proportion of the sheep raising industry in the national economy has also increased year by year. . According to data from the Food and Agriculture Organization of the United Nations (FAO), in 2013, the number of goats in mainland China reached 183 million. In 2014, the number of goats in mainland China was 188 million. Although the number of sheep raised in my country ranks first in the world, compared with countries with devel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/295A61K39/245A61P31/22A61K39/02A61P31/04
CPCA61K39/0241A61K39/12A61K2039/521A61K2039/5252A61K2039/552A61K2039/70A61P31/04A61P31/22C12N2710/24234
Inventor 陈小云王磊杜吉革张敏王静文朱真薛麒
Owner CHINA INST OF VETERINARY DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products